CNMD — CONMED Corp
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 816956 ·
Last close
$38.48
Market Cap
$1.16B
52W High
$40.64
52W Low
$31.44
ADV30
632,362
Next earnings
2026-07-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 317,046,000 | 183,447,000 | 25,415,000 | 13,828,000 | 2,314,942,000 | 35,030,000 | 1,297,269,000 |
| Dec 2025 | 373,198,000 | 218,285,000 | 36,624,000 | 16,739,000 | 2,325,749,000 | 40,817,000 | 1,292,652,000 |
| Sep 2025 | 337,926,000 | 166,119,000 | 11,879,000 | 2,859,000 | 2,322,488,000 | 38,929,000 | 1,314,225,000 |
| Jun 2025 | 342,345,000 | 188,320,000 | 38,161,000 | 21,421,000 | 2,328,458,000 | 33,935,000 | 1,325,588,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$142,627,000
Investing CF
$-13,919,000
Financing CF
$-129,975,000
CapEx
$-18,919,000
Dividends Paid
$-18,566,000
Buybacks
$-37,017,000
EPS Diluted TTM
$1.77
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$602,594,000
Inventory
$366,106,000
Receivables
$228,661,000
ST Investments
—
EBIT TTM
$111,661,000
Pretax Income TTM
$81,800,000
Interest Exp TTM
$29,861,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,370,514,048
EBITDA
$212,555,008
Free Cash Flow
$127,055,128
Enterprise Value
$1,930,544,384
Total Cash
$35,030,000
Total Debt
$860,867,968
Shares Out
30,109,194
Trailing EPS
$1.77
Book Value
$33.76
ROE
5.5%
ROA
3.8%
Div Yield
2.18%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,374,724,000 | 102,622,000 | 47,055,000 | 2,325,749,000 | 1,292,652,000 | — | 170,689,000 |
| Dec 2024 | 1,307,015,000 | 200,326,000 | 132,423,000 | 2,306,247,000 | 1,343,566,000 | — | 166,968,000 |
| Dec 2023 | 1,244,744,000 | 120,603,000 | 64,459,000 | 2,300,021,000 | 1,465,799,000 | — | 125,348,000 |
| Dec 2022 | 1,045,472,000 | 70,054,000 | -80,582,000 | 2,297,592,000 | 1,552,047,000 | — | 33,365,000 |
TTM Snapshot
Revenues TTM
$1,145,194,000
NetIncome TTM
$125,919,000
OpCashFlow TTM
$0
Assets (Latest)
$2,306,247,000
Forward EPS
$4.72
Max Pain — expiry 2026-07-17 (volume-derived — Yahoo OI feed degraded)
max pain strike: $40.00 · spot: $38.48 · call volume: 468 · put volume: 18
Expected Move to 2026-07-17:
±$3.98
(10.33%) —
implied range
$34.50 –
$42.45
· ATM straddle on $40.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AVNS | AVANOS MEDICAL, INC. | $1.17B | $24.93 | — |
| DRTS | Alpha Tau Medical Ltd. | $1.15B | $12.71 | — |
| AORT | ARTIVION, INC. | $1.17B | $24.09 | — |
| PRCT | PROCEPT BioRobotics Corp | $1.19B | $20.89 | — |
| CDRE | Cadre Holdings, Inc. | $1.24B | $28.95 | — |
News headlines (Yahoo Finance, 1h cache)
CNMD Stock Surges As Much As 10% After-Hours On Reports Of Private Equity Takeover Interest
2026-07-11 00:28 · Yahoo
3 Healthcare Stocks We Think Twice About
2026-07-09 11:49 · Yahoo
3 Value Stocks Walking a Fine Line
2026-07-06 11:08 · Yahoo
CONMED (CNMD) Stock Fair Value Moves Lower As Analysts Turn More Cautious
2026-07-04 01:09 · Yahoo
3 Stocks Under $50 We Keep Off Our Radar
2026-07-03 16:50 · Yahoo
CONMED Corporation to Report Second Quarter 2026 Financial Results on July 29, 2026
2026-07-02 20:05 · Yahoo
1 Profitable Stock with Solid Fundamentals and 2 That Underwhelm
2026-06-30 08:41 · Yahoo
Why CONMED (CNMD) Shares Are Falling Today
2026-06-29 22:10 · Yahoo
CONMED Lagging Medtech Peers as Growth Slows, BofA Securities Says
2026-06-29 15:06 · Yahoo
Will CONMED’s New CFO Shift CNMD’s Financial Playbook Or Deepen Its Existing Strategy?
2026-06-21 11:09 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.